tiprankstipranks
Trending News
More News >
Zai Lab Ltd (HK:9688)
FRANKFURT:9688

Compare Zai Lab Ltd (9688) vs. Competitors

Compare
7 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Zai Lab Ltd
HK$22.18
HK$16.21B
-9.55
-25.21%
5 Buy
2 Hold
0 Sell
Moderate Buy
Alphamab Oncology
HK$9.58
HK$10.65B
41.67
223.37%
2 Buy
0 Hold
0 Sell
Moderate Buy
RemeGen Co. Ltd. Class H
HK$94.65
HK$57.70B
-50.14
680.94%
4 Buy
3 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$23.96
HK$40.05B
-24.53
134.70%
0 Buy
1 Hold
1 Sell
Moderate Sell
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$9.91B
-47.34
123.11%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$58.60
HK$36.41B
40.91
183.90%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:9688
Zai Lab Ltd
14.51
-4.41
-23.31%
HK:9966
Alphamab Oncology
10.93
7.66
234.25%
HK:9995
RemeGen Co. Ltd. Class H
94.65
82.91
706.22%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
25.16
14.86
144.27%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.33
2.97
125.85%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
67.00
43.80
188.79%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts